
Sandeep Parmar
About Sandeep Parmar
Data last updated:
Sandeep Parmar is a Director at Aquatic Remedies Limited (since 2020) and Director at Aquatic Formulations (India) Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1,346 Cr; the largest is Aquatic Remedies Limited at ₹1,226 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Dec 2020 | 1996 | ₹1,226 Cr (FY 2025) | Active | |
| Director | 07 Sep 2023 | 1999 | ₹120 Cr (FY 2025) | Active |
Board colleagues of Sandeep Parmar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandeep Parmar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandeep Parmar
Sandeep Parmar currently holds 2 directorships: Aquatic Remedies Limited (Director, since 28 Dec 2020, revenue ₹1,226 Cr (FY 2025)); Aquatic Formulations (India) Limited (Director, since 07 Sep 2023, revenue ₹120 Cr (FY 2025)).
Sandeep Parmar was first appointed on 28 Dec 2020 as Director at Aquatic Remedies Limited. The most recent appointment on record is 07 Sep 2023 at Aquatic Formulations (India) Limited.
The 2 current companies of Sandeep Parmar that report revenue have a combined latest revenue of ₹1,346 Cr: Aquatic Remedies Limited ₹1,226 Cr (FY 2025); Aquatic Formulations (India) Limited ₹120 Cr (FY 2025).
The current boards of Sandeep Parmar's companies include Akshay Kishor Shah (Aquatic Remedies Limited), Bharat Nyalchand Mehta (Aquatic Remedies Limited), Darshan Bhogilal Mehta (Aquatic Remedies Limited), Darshan Bhogilal Mehta (Aquatic Remedies Limited), Hemant Bhogilal Mehta (Aquatic Remedies Limited), Hitendra Nihalchand Mehta (Aquatic Remedies Limited), among others.